PolyCore Therapeutics
Philadelphia
About PolyCore Therapeutics
PolyCore Therapeutics’ experienced team of scientists and life sciences professionals is dedicated to developing breakthrough treatments for CNS Diseases.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $6.5M
- Funding stage: Seed
- Last round: Seed (Apr 2022)
- Website: polycoretherapeutics.com
- Phone: [email protected]
Industries & Categories
Health Care, Professional Services, Therapeutics
Canonical: https://fsome.com/organization/polycore-therapeutics-74994 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.